236 related articles for article (PubMed ID: 20959490)
1. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.
Chen Y; Deng J; Fujimoto J; Kadara H; Men T; Lotan D; Lotan R
Cancer Res; 2010 Nov; 70(21):8917-26. PubMed ID: 20959490
[TBL] [Abstract][Full Text] [Related]
2. Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.
Deng J; Fujimoto J; Ye XF; Men TY; Van Pelt CS; Chen YL; Lin XF; Kadara H; Tao Q; Lotan D; Lotan R
Cancer Prev Res (Phila); 2010 Apr; 3(4):424-37. PubMed ID: 20354164
[TBL] [Abstract][Full Text] [Related]
3. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
4. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
[TBL] [Abstract][Full Text] [Related]
5. A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas.
Kadara H; Fujimoto J; Men T; Ye X; Lotan D; Lee JS; Lotan R
Neoplasia; 2010 Jun; 12(6):499-505. PubMed ID: 20563252
[TBL] [Abstract][Full Text] [Related]
6. Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling.
Quaglino A; Schere-Levy C; Romorini L; Meiss RP; Kordon EC
Breast Cancer Res; 2007; 9(5):R69. PubMed ID: 17925034
[TBL] [Abstract][Full Text] [Related]
7. Epithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposure.
Wang X; Xu D; Liao Y; Zhong S; Song H; Sun B; Zhou BP; Deng J; Han B
Oncotarget; 2015 Nov; 6(37):39578-93. PubMed ID: 26447616
[TBL] [Abstract][Full Text] [Related]
8. Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality.
Guo W; Hu M; Wu J; Zhou A; Liao Y; Song H; Xu D; Kuang Y; Wang T; Jing B; Li K; Ling J; Wen D; Wu W
Biomed Pharmacother; 2019 Jun; 114():108791. PubMed ID: 30901718
[TBL] [Abstract][Full Text] [Related]
9. [Effects of transfected SOCS3 gene on proliferation of human lung adenocarcinoma cell line A549].
Yu ZB; Min JX; Bai L; Yao K; Zhang GQ
Ai Zheng; 2004 Sep; 23(9):1047-51. PubMed ID: 15363199
[TBL] [Abstract][Full Text] [Related]
10. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
11. Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.
Fujimoto J; Kadara H; Men T; van Pelt C; Lotan D; Lotan R
PLoS One; 2010 Jul; 5(7):e11847. PubMed ID: 20686609
[TBL] [Abstract][Full Text] [Related]
12. GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development.
Song H; Sun B; Liao Y; Xu D; Guo W; Wang T; Jing B; Hu M; Li K; Yao F; Deng J
Int J Cancer; 2019 Feb; 144(4):777-787. PubMed ID: 29992578
[TBL] [Abstract][Full Text] [Related]
13. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
[TBL] [Abstract][Full Text] [Related]
14. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.
Fujimoto J; Kadara H; Garcia MM; Kabbout M; Behrens C; Liu DD; Lee JJ; Solis LM; Kim ES; Kalhor N; Moran C; Sharafkhaneh A; Lotan R; Wistuba II
J Thorac Oncol; 2012 Dec; 7(12):1747-1754. PubMed ID: 23154545
[TBL] [Abstract][Full Text] [Related]
15. EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.
Lin X; Zhong S; Ye X; Liao Y; Yao F; Yang X; Sun B; Zhang J; Li Q; Gao Y; Wang Y; Liu J; Han B; Chin YE; Zhou BP; Deng J
Mol Cancer; 2014 Oct; 13():233. PubMed ID: 25311788
[TBL] [Abstract][Full Text] [Related]
16. IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung.
Jing B; Wang T; Sun B; Xu J; Xu D; Liao Y; Song H; Guo W; Li K; Hu M; Zhang S; Ling J; Kuang Y; Zhang T; Zhou BP; Yao F; Deng J
Cancer Res; 2020 Feb; 80(4):784-797. PubMed ID: 31848193
[TBL] [Abstract][Full Text] [Related]
17. LIF-JAK1-STAT3 signaling delays contact inhibition of human corneal endothelial cells.
Liu X; Tseng SC; Zhang MC; Chen SY; Tighe S; Lu WJ; Zhu YT
Cell Cycle; 2015; 14(8):1197-206. PubMed ID: 25695744
[TBL] [Abstract][Full Text] [Related]
18. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
[TBL] [Abstract][Full Text] [Related]
19. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
Zhang L; Li L; Gao G; Wei G; Zheng Y; Wang C; Gao N; Zhao Y; Deng J; Chen H; Sun J; Li D; Zhang X; Liu M
Int J Cancer; 2017 Jun; 140(12):2734-2747. PubMed ID: 28316092
[TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells.
Huang WL; Yeh HH; Lin CC; Lai WW; Chang JY; Chang WT; Su WC
Mol Cancer; 2010 Dec; 9():309. PubMed ID: 21122157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
